Amarantus Bioscience Holdings Establishes Office in Geneva, Switzerland; Appoints Mark Wakefield as Head of Clinical Development Across Amarantus' Diagnostic and Therapeutic Divisions
Concurrently, the Company has appointed Mr. Mark Wakefield as Head of Clinical Development across Amarantus' diagnostic and therapeutic divisions. Mr. Wakefield brings over 15 years of experience, of which the last 8 years focused on establishing and implementing development strategies and operations as Head of Clinical Development Operations at Addex Pharma SA (Switzerland).